ethacetin
Greenlighter
- Joined
- Dec 26, 2009
- Messages
- 18
Wondering if anyone here has information about N,N'-Dicyclopentyl-2-(methylthio)-5-nitro-4,6-pyrimidinediamine, otherwise known as GS-39783.
It acts as a positive allosteric modulator for the GABAb receptor and has been shown to produce anxiolytic effects in animal studies, as well as reduce self-administration of ethanol, nicotine and cocaine.
Some of the reasons given in the abstracts I browsed through for looking into this and pharmacologically similar compounds were to better understand the role of GABAb in anxiety and depression and to hopefully develop new anxiolytics that didn't have the side effects associated with baclofen or benzodiazepines.
Other positive modulators of GABAb I found the most information on include CGP-7930, BHFF, BHF-177, and BSPP.
Does anyone know if there has been any talk of human trials on these compounds or promising new pharmaceuticals?
It acts as a positive allosteric modulator for the GABAb receptor and has been shown to produce anxiolytic effects in animal studies, as well as reduce self-administration of ethanol, nicotine and cocaine.
Some of the reasons given in the abstracts I browsed through for looking into this and pharmacologically similar compounds were to better understand the role of GABAb in anxiety and depression and to hopefully develop new anxiolytics that didn't have the side effects associated with baclofen or benzodiazepines.
Other positive modulators of GABAb I found the most information on include CGP-7930, BHFF, BHF-177, and BSPP.
Does anyone know if there has been any talk of human trials on these compounds or promising new pharmaceuticals?